1.A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study.
Yunju JO ; Eunkyoung PARK ; Sang Bong AHN ; Young Kwan JO ; Byungkwan SON ; Seong Hwan KIM ; Young Sook PARK ; Hyo Jeong KIM
Gut and Liver 2015;9(5):607-614
BACKGROUND/AIMS: Proton pump inhibitors (PPIs) act by irreversibly binding to the H+-K+-ATPase of the proton pump in parietal cells and may possibly affect the vacuolar H+-ATPase in osteoclasts. METHODS: We investigated the effect of 8 weeks of PPI treatment on the parameters of bone turnover and compared PPI with revaprazan, which acts by reversibly binding to H+-K+-ATPase in proton pumps. This study was a parallel randomized controlled trial. For 8 weeks, either a PPI or revaprazan was randomly assigned to patients with gastric ulcers. The parameters of bone turnover were measured at the beginning of and after the 8-week treatment period. RESULTS: Twenty-six patients (PPI, n=13; revaprazan, n=13) completed the intention-to-treat analysis. After the 8-week treatment period, serum calcium and urine deoxypyridinoline (DPD) were increased in the PPI group (serum calcium, p=0.046; urine DPD, p=0.046) but not in the revaprazan group. According to multivariate linear regression analysis, age > or =60 years was an independent predictor for the changes in serum calcium and urine DPD. CONCLUSIONS: In elderly patients, administering a PPI for 8 weeks altered bone parameters. Our study suggested that PPIs might directly alter bone metabolism via the vacuolar H+-ATPase in osteoclasts.
Aged
;
Amino Acids/drug effects/urine
;
Bone Remodeling/*drug effects
;
Bone and Bones/*metabolism
;
Calcium/blood
;
Female
;
Humans
;
Intention to Treat Analysis
;
Linear Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Osteoclasts/*metabolism
;
Prospective Studies
;
Proton Pump Inhibitors/*pharmacology
;
Pyrimidinones/*pharmacology
;
Tetrahydroisoquinolines/*pharmacology
2.Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients.
Sun Chul KIM ; Hyo Jung CHANG ; Myung Gyu KIM ; Sang Kyung JO ; Won Yong CHO ; Hyoung Kyu KIM
Kidney Research and Clinical Practice 2015;34(1):28-34
BACKGROUND: Pulmonary hypertension (PHT) is a recently recognized complication of chronic kidney disease. In this study, we investigated the association between PHT, peripheral vascular calcifications (VCs), and major cardiovascular events. METHODS: In this retrospective study, we included 172 end-stage renal disease (ESRD) patients undergoing dialysis [hemodialysis (HD)=84, peritoneal dialysis=88]. PHT was defined as an estimated pulmonary artery systolic pressure >37 mmHg using echocardiography. The Simple Vascular Calcification Score (SVCS) was measured using plain radiographic films of the hands and pelvis. RESULTS: The prevalence of PHT was significantly higher in HD patients (51.2% vs. 22.7%). Dialysis patients with PHT had a significantly higher prevalence of severe VCs (SVCS> or =3). In multivariate analysis, the presence of severe VCs [odds ratio (OR), 2.68], mitral valve disease (OR, 7.79), HD (OR, 3.35), and larger left atrial diameter (OR, 11.39) were independent risk factors for PHT. In addition to the presence of anemia, severe VCs, or older age, the presence of PHT was an independent predictor of major cardiovascular events in ESRD patients. CONCLUSION: The prevalence of PHT was higher in HD patients and was associated with higher rates of major cardiovascular events. Severe VCs are thought to be an independent risk factor for predicting PHT in ESRD patients. Therefore, in dialysis patients with PHT, careful attention should be paid to the presence of VCs and the occurrence of major cardiovascular events.
Anemia
;
Blood Pressure
;
Cardiovascular Diseases
;
Dialysis*
;
Echocardiography
;
Hand
;
Humans
;
Hypertension, Pulmonary*
;
Kidney Failure, Chronic
;
Mitral Valve
;
Multivariate Analysis
;
Pelvis
;
Prevalence
;
Pulmonary Artery
;
Renal Insufficiency, Chronic
;
Retrospective Studies
;
Risk Factors
;
Vascular Calcification*
;
X-Ray Film
3.Intra-abdominal hypertension does not predict renal recovery or in-hospital mortality in critically ill patients with acute kidney injury.
Hyo Jeong CHANG ; Jihyun YANG ; Sun Chul KIM ; Myung Gyu KIM ; Sang Kyung JO ; Won Yong CHO ; Hyoung Kyu KIM
Kidney Research and Clinical Practice 2015;34(2):103-108
BACKGROUND: Although emerging evidence suggests that intra-abdominal hypertension (IAH) is a predictor of the development of acute kidney injury (AKI), it remains unclear whether the presence of IAH is a predictor of prognosis in patients with AKI. The purpose of this study was to assess whether the presence of IAH could predict prognosis in critically ill patients with AKI. The prognostic value of urinary biomarkers was also determined. METHODS: In this prospective observational study, we enrolled 57 patients with established AKI, who were admitted to the intensive care unit between February 2012 and June 2014. IAH was defined as a sustained elevation in intra-abdominal pressure of > or =12 mmHg, in three consecutive measurements performed daily on the first 3 days. Urinary neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid-binding protein, and simplified acute physiology score II score at the time of admission were also examined. RESULTS: IAH was observed in 78.9% of patients. The in-hospital mortality was 21.1%, and renal recovery during hospitalization was achieved in 40.4% of patients. Although high urinary NGAL [odds ratio (OR), 1.015] and liver-type fatty acid-binding protein (OR, 1.003) were found to be independent predictors of renal recovery, IAH was not. High urinary NGAL (OR, 1.003) and a high simplified acute physiology score II score (OR, 1.102) were independent predictors of in-hospital mortality, while IAH or urinary liver-type fatty acid-binding protein was not. CONCLUSION: Although IAH is prevalent in critically ill patients with AKI, it did not predict AKI prognosis. However, urinary NGAL was found to be a useful predictor of both renal recovery and in-hospital mortality.
Acute Kidney Injury*
;
Biomarkers
;
Critical Illness*
;
Hospital Mortality*
;
Hospitalization
;
Humans
;
Intensive Care Units
;
Intra-Abdominal Hypertension*
;
Lipocalins
;
Neutrophils
;
Observational Study
;
Physiology
;
Prognosis
;
Prospective Studies
4.Accuracy of frozen section diagnosis for ovarian tumors according to histologic type and malignant potential.
Jae Hong NO ; Hoenil JO ; Hyun Joo KOH ; Ji Hye HAN ; Jae Weon KIM ; Noh Hyun PARK ; Yong Sang SONG ; Soon Beom KANG ; Hyo Pyo LEE
Korean Journal of Gynecologic Oncology 2007;18(1):48-53
OBJECTIVE: The purpose of this was to evaluate accuracy of frozen section diagnosis for ovarian tumors according to histologic type and malignant potential. METHODS: We compared the frozen section and final diagnosis of patients with ovarian tumors from April 2001 to April 2006. Of these 1138 cases, 628 cases (55.2%) were epithelial ovarian tumors. Benign, borderline, and malignant epithelial tumors were 380 (60.5%), 87 (13.9%), and 161 (25.6%) cases. The accuracy of frozen section diagnosis was analyzed according to histologic type and malignancy potential. RESULTS: The overall accuracy of frozen section diagnosis was 93.9%. The accuracy for benign, borderline, and malignant tumors were 93%, 92%, and 98%, respectively. The accuracy of frozen section diagnosis was significantly low in mucinous tumors and borderline malignant tumors. However the borderline malignancy was the only independent factor associated with the inaccuracy of frozen section diagnosis (OR: 12.2, 95% CI: 6.5-23.1). The sensitivity for immature teratoma was as low as 63.6%. CONCLUSION: Our data shows that the accuracy is low in mucinous tumors, borderline tumors, and immature teratomas and the borderline malignancy is independent factor associated with inaccuracy of frozen section diagnosis.
Carcinoma
;
Diagnosis*
;
Frozen Sections*
;
Humans
;
Mucins
;
Ovarian Neoplasms
;
Teratoma
5.Mixed Large Cell Neuroendocrine Tumor and Adenocarcinoma of the Ovary.
Wonjeong YOO ; Noh Hyun PARK ; Hoenil JO ; Soo Jin CHAE ; Hye Sil SEOL ; In Ae PARK ; Jae Weon KIM ; Yong Sang SONG ; Soon Beom KANG ; Hyo Pyo LEE
Korean Journal of Obstetrics and Gynecology 2006;49(9):1999-2003
Neuroendocrine tumor is a very heterogenous group arising from the neuroendocrine cells. Especially, large cell neuroendocrine tumor of the ovary is a extremely rare aggressive neoplasm, characteristically arising in association with a surface epithelial tumor. This report describes a mixed type of large cell neuroendocrine carcinoma and adenocarcinoma of the ovary. A 63-year old woman presented with abdominal distension and discomfort underwent staging laparotomy under the impression of ovarian cancer. The operation revealed an small ovarian mass with invasion of multiple region in peritoneal cavity by the tumor. Immunohistochemical and ultrastructural analysis confirmed the neuroendocrine nature of the tumor. The adenocarcinoma in this case is mixture of mucinous and endometrioid type. A diagnosis of stage IIIc mixed large cell neuroendocrine tumor and adenocarcinoma of the ovary was rendered. She is subsequently being treated with Paclitaxel and Carboplatin combination chemotherapy.
Adenocarcinoma*
;
Carboplatin
;
Carcinoma, Neuroendocrine
;
Diagnosis
;
Drug Therapy, Combination
;
Female
;
Humans
;
Laparotomy
;
Middle Aged
;
Mucins
;
Neuroendocrine Cells
;
Neuroendocrine Tumors*
;
Ovarian Neoplasms
;
Ovary*
;
Paclitaxel
;
Peritoneal Cavity
6.Usefulness of B-type Natriuretic Peptide in Congestive Heart Failure.
Soon Hyo KWON ; Young Keun ON ; Dae Hee HAN ; Sang Chul LEE ; Yoon Hang JO ; Nae Hee LEE ; Min Su HYUN ; Sung Koo KIM ; Young Joo KWON
Korean Circulation Journal 2003;33(8):695-700
BACKGROUND AND OBJECTIVES: B-type natriuretic peptide (BNP) is released from the cardiac ventricles in response to increased wall tension. Early diagnosis of congestive heart failure (CHF) and assessment of the left ventricular end diastolic pressure (LVEDP) are thought to be important in the diagnosis, treatment and follow up of patients with CHF. SUBJECTS AND METHODS: Between March, 2002 and November, 2002, 50 patients, who were admitted for treatment and hemodynamic monitoring, were studied. For the BNP measurement, 3 to 5ml blood samples were collected into tubes containing EDTA. The BNP was measured with a fluorescence immunoassay kit (Triage, Biosite, San Diego, U.S.A.). Cardiac Catheterization was performed for the assessment of the LVEDP. RESULTS: Of the 50 subjects, 34 with CHF had a mean BNP level of 483.1+/-77.8 pg/mL, whereas those without CHF had a level of 79.2+/-24.0 pg/mL. The difference between the groups was statistically significant (p=0.005). A significant positive correlation was seen between the BNP and the LVEDP (r=0.53, p=0.001). The correlation between the BNP and the left ventricular ejection fraction (LVEF) was not statistically significant (r=-0.226, p=0.198). CONCLUSION: The plasma BNP was significantly increased in CHF, and might reflect the LVEDP. Further study will be required to see whether the BNP is a useful parameter for the staging and treatment of CHF.
Blood Pressure
;
Cardiac Catheterization
;
Cardiac Catheters
;
Diagnosis
;
Early Diagnosis
;
Edetic Acid
;
Estrogens, Conjugated (USP)*
;
Fluorescence
;
Follow-Up Studies
;
Heart Failure*
;
Heart Ventricles
;
Hemodynamics
;
Humans
;
Immunoassay
;
Natriuretic Peptide, Brain*
;
Plasma
;
Stroke Volume
;
Ventricular Pressure
7.Relationship between Low Back Pain and Physical Characteristics in Flight Attendants.
Hyun Mee HAN ; Yun Young NAM ; Jun Hyo JO ; Sang Chul ROH ; Woo Hae KWAK ; Ju Na LEE ; No Won PARK ; Duck Hee CHAE ; Won Keun LEE
Korean Journal of Aerospace and Environmental Medicine 2002;12(3):171-175
BACKGROUND: Low back pain (LBP) is known to be the significant reason for absenteeism and can develop long-term disability. So the airline authorities have made an effort to reduce the incidence of LBP by applying their physical standards. As a LBP Prevention Program, Airline A has provided health education, counseling and physical examinations. The purpose of this study is to analyze the relationship between LBP and physical characteristics, age and work duration, and this result will provide basic information for improving the LBP Prevention Program. METHOD: The subjects were the 585 flight attendants who had undergone regular physical check-ups with Airline A Medical Center from October 2000 to September 2001. We reviewed their absence records and physical characteristics, age and work duration. These data were analyzed statistically by the t-test and Lositic regression. RESULT: The LBP history group accounted for 18% of the study group. The male LBP history group had the more thin waist than the no history group. There were no differences (P<0.05) between LBP and other male and female physical characteristics. The age and work duration of male LBP history group was lower than the no history group (P<0.05). But the female comparison revealed that only the work experience in the LBP history group was lower than the No history group (P<0.05). Waist, age, work duration was analyzed statistically by logistic regression. Only female's work experience was significant. The fewer work experience was the more LBP. CONCLUSION: The results of this study suggest LBP is associated with work experience rather than physical characteristics. This is the first step toward improving a LBP Prevention Program for the cabin crew. It will be useful to conduct another review to assess various other reasons, such as psychosocial job factors, duration of work disability and muscle strength, related to LBP.
Absenteeism
;
Counseling
;
Female
;
Health Education
;
Humans
;
Incidence
;
Logistic Models
;
Low Back Pain*
;
Male
;
Muscle Strength
;
Physical Examination
8.Experience of the Pediatric Patients Consulted to Pain Center.
Hyo Min LEE ; Chul Joong LEE ; Mi Geum LEE ; Ji Yon JO ; Yun Suk CHOI ; Mae Hwa KANG ; Yong Chul KIM ; Sung Eun SIM ; Sang Chul LEE
Anesthesia and Pain Medicine 2007;2(1):4-8
BACKGROUND: The aim of this study was to investigate the management of pediatric patients who were referred to the pain center. METHODS: The data was collected based on 32 pediatric patients referred to the pain center from March 2002 to August 2006. The number of patients each year, gender distribution, age, requested departments, clinical causes of consultation, and the pain management before and after the consultation were analyzed retrospectively. RESULTS: 32 pediatric patients (19 males and 13 females), aged 3- 17 years, were enrolled in this study. Fifty-six percent of patients were in adolescence. The major need for the consultation was cancer pain (50.0%), myofascial pain syndrome (10.0%) and central pain (10.0%). Before the consultation, 62.1% of the patients were managed by opioid-based medications of which 26.1% were managed by only partial agonists and 29.6% were managed by only PRN. At the pain center, opioid-based medication was also the main treatment. CONCLUSIONS: The number of pediatric patients referred to the pain center has increased. Under this condition, the pain physician should be concerned about pediatric pain patients and their management.
Adolescent
;
Age Distribution
;
Humans
;
Male
;
Myofascial Pain Syndromes
;
Pain Clinics*
;
Pain Management
;
Retrospective Studies
9.Platelet Function Assay for Clopidogrel and Ticlopidine in Patients With Ischemic Stroke.
Jae Guk KIM ; Sang Jun LEE ; Sung Rae JO ; Jin Ok KIM ; Hyo Jeong KIM ; Dong Joo YUN ; Yungchai KO ; Gun Sei OH ; Soo Joo LEE
Journal of the Korean Neurological Association 2011;29(3):184-191
BACKGROUND: The rapid platelet function assay (RPFA) has recently been developed and used to monitor the antiplatelet effects on the P2Y12 ADP receptor. We describe the platelet response to clopidogrel and ticlopidine using the RPFA and identify the clinical factor related to laboratory resistance in patients with ischemic stroke. METHODS: Of the 172 outpatients with ischemic stroke or transient ischemic attack (TIA) enrolled in this study, 86 were taking clopidogrel (75 mg/day) and 86 were taking ticlopidine (500 mg/day). Demographic data, vascular risk factors, stroke subtypes, and the results of blood tests were recorded. Inhibition is described as the percentage change from baseline aggregation, and is calculated from the P2Y12 reaction unit (PRU) and the base PRU on the RPFA. Those patients who displayed ineffective aggregation-inhibition (inhibition <20%) on the RPFA were defined as nonresponders. RESULTS: The response of platelet aggregation-inhibition to clopidogrel and ticlopidine exhibited a variable distribution (PRU; coefficient of variability, 0.477). Ineffective platelet inhibition was detected in 25.6% of the clopidogrel group and 3.5% of the ticlopidine group (p<0.001). In addition to clopidogrel, TIA and diabetes exhibited significantly higher ineffective platelet inhibition in a univariate analysis. In the multivariate analysis, clopidogrel and TIA remained significant, and diabetes fell to borderline significance (p=0.061). CONCLUSIONS: The response to clopidogrel and ticlopidine can vary between patients. Platelet inhibition is lower for clopidogrel than for ticlopidine on the platelet function test in patients with ischemic stroke. The clinical impact of these results remains uncertain; further investigations are needed.
Blood Platelets
;
Hematologic Tests
;
Humans
;
Ischemic Attack, Transient
;
Multivariate Analysis
;
Organothiophosphorus Compounds
;
Outpatients
;
Platelet Function Tests
;
Receptors, Purinergic P2
;
Risk Factors
;
Stroke
;
Ticlopidine
10.Assessment of change of coronary artery flow using corrected TIMI frame count following abciximab adminstration during primary angioplasty for acute myocardial infarction.
Hae Ok JUNG ; Ki Bae SEUNG ; Jung Won JANG ; Sang Hyun LIM ; Ki Yuk JANG ; Hyo Young LIM ; Wook Sung CHUNG ; Jong Jin KIM ; Jang Sung CHAE ; Jae Hyung KIM ; Soon Jo HONG ; Kyu Bo CHOI
Korean Circulation Journal 2000;30(7):803-810
BACKGROUND: In spite of the successful reperfusion therapy, coronary blood flow in infarcted myocardium was known to decrease for a long time. Abciximab is known to inhibit the final pathway of platelet aggregation and maintenance the large vessel patency. But abciximab may have another important effect beyond the these effect. TIMI frame count method is simple, reproducible, objective and quantitative index of coronary flow. We tried to define the effect of abciximab that used with primary angioplasty on the coronary blood flow using TIMI frame count methods. METHODS: We consecutively studied 30 patients who admitted for acute myocardial infarction without cardiogenic shock from September 1997 to August 1999. We analyzed the changes of corrected TIMI frame count(CTFC) between the baseline(immediate after the angioplasty) and follow-up(post-op 7th day) coronary angiogram and compared the results between the group of primary angioplasty with abciximab(abciximab group, n=1) and the group of primary angioplasty without abciximab(non-abciximab group, n=9). RESULTS: There were no differences between abciximab group and non-abciximab group in baseline characteristics, treatment modalities and angiographic results. According to the results of the comparison of deltaCTFC, changing rate of CTFC, deltavelocity and changing rate of velocity, there were significant improvement of the coronary blood flow in infarct related artery in the abciximab group than non-abciximab group. But there were no differences in the changes of coronary blood flow in non-infarct related artery between two groups. The frequency of major adverse coronary events during follow up periods(mean 6 months) were similar(9.1% and 5.2% each other, p>0.05). CONCLUSIONS: Abciximab used with primary angioplasty in acute myocardial infarction improved the coronary blood flow significantly in infarcted myocardium. This finding may be related that abciximab enhance the perfusion and function of microvasculature in infarcted myocardium.
Angioplasty*
;
Arteries
;
Coronary Vessels*
;
Follow-Up Studies
;
Humans
;
Microvessels
;
Myocardial Infarction*
;
Myocardium
;
Perfusion
;
Platelet Aggregation
;
Reperfusion
;
Shock, Cardiogenic